Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

9.5%

Beneficial ownership of this reported class.

Shares

6,666,540 shares

Shares beneficially owned as disclosed.

Event date

26 Jun 2025

Date tied to the ownership event or amendment.

Accepted by SEC

30 Jun 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
KYMR
Shares outstanding
70,174,105 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
30 Jun 2025, 20:26:26 UTC
Event date
26 Jun 2025
Next SEC filing
11 Dec 2025
Source filing
View source filing

Key filing fact

BAKER BROS. ADVISORS LP disclosed 9.5% ownership in Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share (KYMR) on 26 Jun 2025.

Key facts

  • BAKER BROS. ADVISORS LP filed SCHEDULE 13D/A for Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share (KYMR).
  • Disclosed ownership: 9.5%.
  • Date of event: 26 Jun 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 30 Jun 2025, 20:26.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (4)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
Baker Bros. Advisors LP 9.5% 6,666,540 6,666,540 0 /s/ Scott L. Lessing Scott L. Lessing/ President By: Baker Bros. Advisors (GP) LLC, its general partner 0001263508
Baker Bros. Advisors (GP) LLC 9.5% 6,666,540 6,666,540 0 /s/ Scott L. Lessing Scott L. Lessing/ President 0001580575
Julian C. Baker 9.5% 6,666,540 6,666,540 0 /s/ Julian C. Baker Julian C. Baker 0001087939
Felix J. Baker 9.5% 6,666,540 6,666,540 0 /s/ Felix J. Baker Felix J. Baker 0001087940
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .